Table A1.
Modified UW Madison (25 week) protocol
Week
| ||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
0 | 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10 | 11 | 12 | 13 | 14 | 15 | 16 | 17 | 18 | 19 | 20 | 21 | 23 | 25 | |
L-aspa | x | |||||||||||||||||||||||
Vincab | x | x | x | x | x | x | x | x | ||||||||||||||||
CTXc | x | x | x | x | ||||||||||||||||||||
DOXOd | x | x | x | x | ||||||||||||||||||||
Prede | x | x | x | x | x | x | x | x | x | x | x | x | x | x | x | x | x | x | x | x | x | x | x | x |
L-asparaginase was given at the discretion of the clinician at a dose of 400 IU kg−1 SQ or 2500 IU cat−1 SQ.
Vincristine or vinblastine was given at the discretion of the prescribing clinician. Vincristine was given at 0.5–0.7mgm−2, IV or vinblastine was given at 1.5mgm−2, IV.
Cyclophosphamide (Cytoxan) was given 200–250mgm−2 IV or PO.
Doxorubicin was given at 1mg kg−1 or 25 mgm−2 IV.
Prednisone or prednisolone was given at 1–2mg kg−1 PO q24 h continued through the protocol to be tapered upon completion. Tapering occurred earlier at the discretion of the clinician.